Korovin S I
Klin Khir. 1998(1):39-40.
The results of treatment of 1128 patients with the body and extremities skin melanoma were analyzed. The increase of five-year survival index in patients with the tumor of T1-4 N0M0 stage by 11.4% was promoted by the postoperative adjuvant endolymphatic chemotherapy application. The dacarbasin endolymphatic infusion together with recombinant interferon laferon have permitted to increase the survival index of patients by 15.4%.
对1128例身体和四肢皮肤黑色素瘤患者的治疗结果进行了分析。术后应用辅助性内淋巴化疗使T1 - 4 N0M0期肿瘤患者的五年生存率指数提高了11.4%。达卡巴嗪内淋巴灌注联合重组干扰素拉费隆使患者的生存率指数提高了15.4%。
